Atjaunināt sīkdatņu piekrišanu

E-grāmata: Leukemia-Lymphoma Cell Line Factsbook

5.00/5 (2 ratings by Goodreads)
(German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany)
  • Formāts: PDF+DRM
  • Sērija : Factsbook
  • Izdošanas datums: 04-Sep-2000
  • Izdevniecība: Academic Press Inc
  • Valoda: eng
  • ISBN-13: 9780080535449
Citas grāmatas par šo tēmu:
  • Formāts - PDF+DRM
  • Cena: 85,66 €*
  • * ši ir gala cena, t.i., netiek piemērotas nekādas papildus atlaides
  • Ielikt grozā
  • Pievienot vēlmju sarakstam
  • Šī e-grāmata paredzēta tikai personīgai lietošanai. E-grāmatas nav iespējams atgriezt un nauda par iegādātajām e-grāmatām netiek atmaksāta.
Leukemia-Lymphoma Cell Line FactsbookPalielināt
  • Formāts: PDF+DRM
  • Sērija : Factsbook
  • Izdošanas datums: 04-Sep-2000
  • Izdevniecība: Academic Press Inc
  • Valoda: eng
  • ISBN-13: 9780080535449
Citas grāmatas par šo tēmu:

DRM restrictions

  • Kopēšana (kopēt/ievietot):

    nav atļauts

  • Drukāšana:

    nav atļauts

  • Lietošana:

    Digitālo tiesību pārvaldība (Digital Rights Management (DRM))
    Izdevējs ir piegādājis šo grāmatu šifrētā veidā, kas nozīmē, ka jums ir jāinstalē bezmaksas programmatūra, lai to atbloķētu un lasītu. Lai lasītu šo e-grāmatu, jums ir jāizveido Adobe ID. Vairāk informācijas šeit. E-grāmatu var lasīt un lejupielādēt līdz 6 ierīcēm (vienam lietotājam ar vienu un to pašu Adobe ID).

    Nepieciešamā programmatūra
    Lai lasītu šo e-grāmatu mobilajā ierīcē (tālrunī vai planšetdatorā), jums būs jāinstalē šī bezmaksas lietotne: PocketBook Reader (iOS / Android)

    Lai lejupielādētu un lasītu šo e-grāmatu datorā vai Mac datorā, jums ir nepieciešamid Adobe Digital Editions (šī ir bezmaksas lietotne, kas īpaši izstrādāta e-grāmatām. Tā nav tas pats, kas Adobe Reader, kas, iespējams, jau ir jūsu datorā.)

    Jūs nevarat lasīt šo e-grāmatu, izmantojot Amazon Kindle.

This book represents an essential reference manual for all of the well-characterized leukemia-lymphoma cell lines currently available. It provides the most important facts, using the succinct and user-friendly format that has made the FactsBooks so popular with scientists and clinical researchers. Introductory chapters provide background and perspective for culturing malignant hematopoietic (blood forming) cell lines. These chapters are followed by over 400 comprehensive individual entries. Each cell line entry highlights essential clinical, immunological, genetic, and functional features and includes a comprehensive listing of references.

Key Features
* the full spectrum of malignant cell lines from all hematopoietic cell lineages
* sister cell lines and relevant subclones
* clinical data: patient, diagnosis, treatment status, and specimen source
* authentication of derivation and availability
* immunophenotype
* cytogenetic karyotype
* translocations and fusion genes
* receptor gene rearrangements and genetic alterations
* cell cultures aspects: establishment, medium, doubling time, growth
* cytochemical profile
* cytokine production and response to cytokines
* proto-oncogene and transcription factor expression/alteration
* functional features: differentiation induction, heterotransplantability
* special unique features
* key references

Recenzijas

"This book is most timely and should be an essential component for all investigators involved in cell culture research." --John Bennett, University of Rochester Medical Center, 2002

Praise for the Series: "...a growing series of excellent manuals." --MOLECULAR MEDICINE TODAY "...essential works of reference..." --TRENDS IN BIOCHEMICAL SCIENCES

Papildus informācija

Key Features * the full spectrum of malignant cell lines from all hematopoietic cell lineages * sister cell lines and relevant subclones * clinical data: patient, diagnosis, treatment status, and specimen source * authentication of derivation and availability * immunophenotype * cytogenetic karyotype * translocations and fusion genes * receptor gene rearrangements and genetic alterations * cell cultures aspects: establishment, medium, doubling time, growth * cytochemical profile * cytokine production and response to cytokines * proto-oncogene and transcription factor expression/alteration * functional features: differentiation induction, heterotransplantability * special unique features * key references
Preface xi
Abbreviations xii
Section I THE INTRODUCTORY CHAPTERS
Introduction
2(10)
History and Classification of Hematopoietic Cell Lines
12(10)
EBV- and HTLV-Positive Cell Lines
22(6)
Guidelines for Characterization of Cell Lines
28(5)
Establishment and Culture of Cell Lines
33(13)
Authentication of Cell Lines
46(7)
Mycoplasma Detection and Elimination
53(18)
Availability of Cell Lines and Cell Line Banks
71(651)
Section II B-CELL LEUKEMIA AND B-CELL LYMPHOMA CELL LINES
Part 1 Precursor B-Cell Lines
207
80(1)
380
81(1)
697
82(2)
A1
84(1)
ALL-1
85(1)
ALL-2
86(1)
ALL/MIK
87(1)
B1
88(1)
BLIN-1
89(1)
BLIN-2
90(1)
BS
91(1)
BV173
92(2)
CEMO-1
94(1)
DUNATIS
95(1)
EU-1
96(1)
EU-8
97(1)
G2
98(1)
HAL-01
99(2)
HBL-3
101(1)
JKB-1
102(1)
KH-3A
103(1)
KLM-2
104(1)
KMO-90
105(1)
KOPN-8
106(1)
KOPN-30bi
107(1)
LAZ 221
108(1)
LEF1
109(1)
MIELIKI
110(1)
MR-87
111(1)
MUTZ-1
112(2)
MY
114(1)
NALM-1
115(2)
NALM-6
117(2)
NALM-16
119(1)
NALM-19
120(1)
NALM-20
121(2)
NALM-24
123(2)
NALM-26
125(1)
NALM-27
126(2)
NALM-29
128(2)
NALM-33
130(1)
OM9;22
131(1)
OZ
132(1)
P30/Ohkubo
133(2)
PALL-2
135(1)
PC-53
136(1)
PER-278
137(1)
Pre-Alp
138(1)
RCH-ACV
139(1)
Reh
140(2)
RS4;11
142(1)
SEM
143(1)
SUP-B2
144(1)
SUP-B7
145(1)
SUP-B13
146(2)
SUP-B24
148(1)
SUP-B26
149(1)
SUP-B27
150(1)
TA-1
151(1)
TC78
152(1)
TMD5
153(1)
TOM-1
154(2)
TS-2
156(1)
UoC-B1
157(1)
UoC-B3
158(1)
UoC-B4
159(1)
W1
160(1)
Z-33
161(1)
Z-119
162(1)
Z-181
163(3)
Part 2 Mature B-Cell Lines
A3/Kawakami
166(2)
A4/Fukuda
168(1)
BAL-KHs
169(1)
BALL-1
170(2)
BALL-2
172(1)
BALM-1
173(1)
BALM-3
174(1)
BALM-7
175(2)
BALM-9
177(2)
BALM-13
179(2)
BALM-16
181(1)
BALM-18
182(1)
Bay91
183(1)
BC-1
184(2)
BC-2
186(1)
BC-3
187(2)
BCBL-1
189(1)
BCP-1
190(1)
BEVA
191(2)
BHL-89
193(1)
BNBH-1
194(1)
BONNA-12
195(1)
Ci-1
196(1)
CRO-AP/2
197(2)
CRO-AP/3
199(2)
CRO-AP/5
201(2)
CTB-1
203(1)
DEAU
204(1)
DoHH2
205(2)
DS
207(1)
DS-1
208(1)
EHEB
209(1)
ESKOL
210(1)
Farage
211(1)
FL-18
212(1)
FL-218
213(1)
FL-318
214(1)
FMC-Hu-1-B
215(1)
Granta 519
216(1)
Hair-M
217(1)
HBL-1
218(1)
HBL-1
219(1)
HBL-2
220(2)
HBL-2
222(1)
HBL-3
223(1)
HC1
224(1)
HF-1
225(1)
HF-4a
226(1)
HT 58
227(1)
JeKo-1
228(1)
JVM-2
229(2)
JVM-3
231(1)
JVM-13
232(1)
KAL-1
233(1)
Karpas 231
234(2)
Karpas 353
236(1)
Karpas 422
237(2)
Karpas 1106P
239(1)
KHM-2B
240(1)
KHM-10B
241(1)
KIS-1
242(2)
KML-1
244(1)
MC116
245(1)
MEC1
246(2)
MN-60
248(1)
NCEB-1
249(1)
OCI-Ly18
250(1)
ONHL-1
251(2)
OPL-1
253(1)
OPL-2
254(1)
PER-377
255(1)
RC-K8
256(1)
Ri-1
257(1)
RL
258(1)
ROS-50
259(1)
Sc-1
260(1)
SKW 4
261(1)
SP-53
262(1)
SU-DHL-4
263(2)
SU-DHL-5
265(1)
SU-DHL-6
266(1)
SU-DHL-7
267(1)
SU-DHL-8
268(1)
SU-DHL-9
269(1)
SU-DHL-10
270(1)
Tanoue
271(2)
TK
273(1)
TMD2
274(1)
Tree92
275(1)
TY-1
276(1)
U-698 M
277(1)
U 2904
278(1)
UoC-B2
279(1)
UoC-B10
280(1)
WSU-CLL
281(1)
WSU-DLCL
282(1)
WSU-FSCCL
283(1)
WSU-NHL
284(2)
WSU-WM
286(1)
YM
287(1)
Z-138
288(3)
Section III MYELOMA AND PLASMA CELL LEUKEMIA CELL LINES
ACB-885
291(1)
AMO1
292(1)
ANBL-6
293(2)
delta-47
295(1)
DOBIL-6
296(2)
EJM
298(1)
FLAM-76
299(1)
FR4
300(2)
Fravel
302(1)
HL461
303(1)
HSM-2
304(1)
JJN-2
305(2)
Karpas 620
307(1)
Karpas 707
308(1)
KMM-1
309(2)
KMS-11
311(1)
KMS-12-PE
312(2)
KMS-18
314(1)
KPMM2
315(1)
L 363
316(2)
LB 84-1
318(1)
LB-831
319(1)
LOPRA-1
320(1)
LP-1
321(2)
MEF-1
323(1)
MM.1
324(1)
MOLP-5
325(2)
MT3
327(1)
NCI-H929
328(2)
NOP-2
330(1)
OPM-2
331(2)
PCM6
333(1)
RPMI 8226
334(2)
SK-MM-1
336(1)
SK-MM-2
337(2)
TH
339(1)
U-226
340(2)
UTMC-2
342(1)
XG-1
343(2)
XG-2
345(2)
XG-3P
347(1)
XG-4
348(2)
XG-5
350(2)
XG-6
352(2)
XG-7
354(6)
Section IV T-CELL LEUKEMIA AND T-CELL LYMPHOMA CELL LINES
Part 1 Immature T-Cell Lines
ALL-SIL
360(2)
Be13
362(1)
CCRF-CEM
363(2)
CML-T1
365(1)
DND-41
366(1)
DU.528
367(1)
EU-9
368(1)
HD-Mar
369(2)
HPB-ALL
371(2)
H-SB2
373(2)
HT-1
375(1)
JK-T1
376(1)
JURKAT
377(2)
Karpas 45
379(2)
KE-37
381(1)
KOPT-K1
382(1)
K-T1
383(1)
L-KAW
384(1)
Loucy
385(1)
MAT
386(1)
MOLT 3
387(2)
MOLT 13
389(2)
MOLT 16
391(2)
MT-ALL
393(1)
P12/Ichikawa
394(2)
Peer
396(2)
PER-117
398(1)
PER-255
399(1)
PF-382
400(1)
PFI-285
401(1)
RPMI 8402
402(2)
ST-4
404(1)
SUP-T1
405(2)
SUP-T2
407(1)
SUP-T3
408(2)
SUP-T4
410(1)
SUP-T6
411(1)
SUP-T7
412(1)
SUP-T8
413(1)
SUP-T9
414(1)
SUP-T10
415(1)
SUP-T11
416(1)
SUP-T12
417(1)
SUP-T13
418(1)
SUP-T14
419(1)
TALL-1
420(2)
TALL-1
422(1)
TALL-101
423(2)
TALL-103/2
425(2)
TALL-104
427(2)
TALL-105
429(1)
TALL-106
430(1)
TALL-107
431(1)
TK-6
432(4)
Part 2 Mature T-Cell Lines
Deglis
436(1)
EBT-8
437(1)
HPB-MLp-W
438(1)
HUT 78
439(2)
HUT 102
441(2)
Karpas 384
443(1)
Kit 225
444(1)
My-La
445(1)
Se-Ax
446(1)
SKW-3
447(2)
SMZ-1
449(1)
T34
450(3)
Section V NATURAL KILLER CELL LEUKEMIA-LYMPHOMA CELL LINES
HANK1
453(1)
KHYG-1
454(2)
NK-92
456(1)
NKL
457(1)
NK-YS
458(2)
NOI-90
460(1)
YT
461(4)
Section VI HODGKIN'S DISEASE CELL LINES
DEV
465(1)
HD-70
466(2)
HDLM-2
468(2)
HD-MyZ
470(2)
HKB-1
472(1)
KM-H2
473(2)
L 428
475(2)
L 540
477(2)
L1236
479(2)
SBH-1
481(1)
SUP-HD1
482(2)
SU/RH-HD-1
484(3)
Section VII ANAPLASTIC LARGE CELL LYMPHOMA CELL LINES
DEL
487(2)
DL-40
489(1)
FE-PD
490(1)
JB6
491(1)
Karpas 299
492(2)
Ki-JK
494(1)
Mac-2A
495(2)
PLyI
497(1)
SR-786
498(2)
SU-DHL-1
500(2)
SUP-M2
502(1)
USP-91
503(5)
Section VIII MYELOID LEUKEMIA CELL LINES
Part 1 Myelocytic Cell Lines
AML14
508(2)
AR230
510(1)
CML-C-1
511(1)
CTS
512(1)
EM-2
513(2)
EoL-1
515(2)
FKH-1
517(1)
GDM-1
518(1)
GF-D8
519(2)
GM/SO
521(1)
HL-60
522(3)
HMC-1
525(2)
HNT-34
527(1)
HT93
528(2)
K051
530(1)
Kasumi-1
531(1)
Kasumi-3
532(1)
Kasumi-4
533(1)
KBM-7
534(2)
KCL-22
536(1)
KG-1
537(2)
KOPM-28
539(1)
KPB-M15
540(1)
KT-1
541(1)
KU812
542(2)
KY821
544(1)
KYO-1
545(1)
LW/SO
546(1)
Marimo
547(1)
MDS92
548(1)
MTO-94
549(1)
MUTZ-2
550(2)
NB4
552(2)
NKM-1
554(1)
OCI/AML1
555(1)
OCI/AML5
556(1)
OHN-GM
557(1)
OIH-1
558(1)
PL-21
559(1)
SKNO-1
560(1)
TSU1621MT
561(1)
UCSD/AML1
562(2)
UF-1
564(1)
YNH-1
565(2)
YOS-M
567(3)
Part 2 Monocytic Cell Lines
AML-1
570(1)
AML-193
571(1)
CTV-1
572(2)
DOP-M1
574(1)
FLG 29.1
575(2)
IMS-M1
577(1)
KBM-3
578(1)
KBM-5
579(2)
KP-1
581(1)
KP-MO-TS
582(1)
ME-1
583(2)
ML-2
585(2)
MOLM-13
587(2)
Mono Mac 6
589(2)
MUTZ-3
591(2)
MV4-11
593(1)
NOMO-1
594(1)
OCI/AML2
595(1)
OMA-AML-1
596(1)
P31/Fujioka
597(1)
P39/Tsugane
598(1)
RC-2A
599(1)
RWLeu-4
600(1)
SCC-3
601(1)
SKM-1
602(1)
THP-1
603(2)
TK-1
605(1)
U-937
606(2)
UG3
608(2)
YK-M2
610(2)
Part 3 Erythrocytic-Megakaryocytic Cell Lines
AP-217
612(1)
AS-E2
613(1)
B1647
614(1)
CHRF-288-11
615(2)
CMK
617(2)
CMS
619(1)
CMY
620(1)
ELF-153
621(1)
F-36P
622(1)
HEL
623(2)
HML
625(2)
HU-3
627(2)
JK-1
629(2)
JURL-MK1
631(1)
K-562
632(2)
KH88
634(2)
KH184
636(1)
KMOE-2
637(2)
LAMA-84
639(2)
M-07e
641(2)
MB-02
643(2)
MC3
645(1)
MEG-01
646(2)
MEG-A2
648(1)
MG-S
649(1)
MHH 225
650(1)
MKPL-1
651(1)
M-MOK
652(2)
MOLM-1
654(1)
NS-Meg
655(2)
OCIM1
657(1)
OCIM2
658(1)
SAM-1
659(1)
SAS413
660(1)
T-33
661(1)
TF-1
662(2)
TN922
664(1)
TS9;22
665(1)
UoC-M1
666(1)
UT-7
667(2)
Y-1K
669(1)
YN-1
670(1)
YS9;22
671(4)
Section IX TABLES
Table I Additional Precursor B-Cell Lines
675(5)
Table II Additional Mature B-Cell Lines
680(7)
Table III Panel of Selected Burkitt's Lymphoma Cell Lines
687(1)
Table IV Additional Myeloma and Plasma Cell Leukemia Cell Lines
688(4)
Table V Additional Immature T-Cell Lines
692(3)
Table VI Additional Mature T-Cell Lines
695(1)
Table VII Panel of Selected Adult T-Cell Leukemia-Lymphoma Cell Lines
696(1)
Table VIII Additional Natural Killer Cell Leukemia-Lymphoma Cell Lines
697(2)
Table IX Additional Hodgkin's Disease Cell Lines
699(1)
Table X Additional Anaplastic Large Cell Lymphoma Cell Lines
700(1)
Table XI Additional Myelocytic Cell Lines
701(3)
Table XII Additional Monocytic Cell Lines
704(2)
Table XIII Additional Erythrocytic-Megakaryocytic Cell Lines
706(2)
Table XIV Growth Factor-Dependent Cell Lines
708(3)
Table XV Cell Lines with Unique Translocations and Fusion Genes
711(4)
Table XVI False and Misinterpreted Cell Lines
715(3)
Table XVII Recommended Reference Cell Lines
718(4)
Index 722


Biežāk uzdotie jautājumi par e-grāmatām Biežāk uzdotie jautājumi par e-grāmatām
Permanent link: https://www.kriso.lv/db/97800805354492e.html
Keywords: